Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
69,068,637
-
Shares change
-
+1,725,349
-
Total reported value, excl. options
-
$384,022,057
-
Value change
-
+$3,627,924
-
Put/Call ratio
-
31.27%
-
Number of buys
-
58
-
Number of sells
-
-44
-
Price
-
$5.56
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2017
147 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q2 2017.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69,068,637 shares
of 209,618,986 outstanding shares and own 32.95% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11,716,784 shares), BlackRock Inc. (6,258,377 shares), VANGUARD GROUP INC (6,007,815 shares), RA CAPITAL MANAGEMENT, LLC (5,162,242 shares), STATE STREET CORP (3,909,013 shares), DEERFIELD MANAGEMENT CO (3,499,202 shares), MILLENNIUM MANAGEMENT LLC (3,405,864 shares), RTW INVESTMENTS, LP (3,333,958 shares), FMR LLC (3,124,676 shares), and VHCP Management II, LLC (2,475,167 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.